Sumitomo Life Insurance Co. Reduces Holdings in Agilent Technologies, Inc. $A

Sumitomo Life Insurance Co. lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,708 shares of the medical research company’s stock after selling 386 shares during the period. Sumitomo Life Insurance Co.’s holdings in Agilent Technologies were worth $674,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Verdence Capital Advisors LLC raised its stake in shares of Agilent Technologies by 5.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after purchasing an additional 86 shares during the period. Valeo Financial Advisors LLC raised its stake in shares of Agilent Technologies by 3.0% during the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares during the period. Cary Street Partners Financial LLC raised its stake in shares of Agilent Technologies by 2.9% during the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares during the period. Stratos Wealth Partners LTD. raised its stake in shares of Agilent Technologies by 0.3% during the 1st quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after purchasing an additional 124 shares during the period. Finally, Athena Investment Management raised its stake in shares of Agilent Technologies by 4.5% during the 1st quarter. Athena Investment Management now owns 2,881 shares of the medical research company’s stock valued at $337,000 after purchasing an additional 125 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Price Performance

A opened at $144.54 on Tuesday. The stock has a 50-day moving average price of $133.49 and a 200-day moving average price of $121.31. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $40.98 billion, a P/E ratio of 33.93, a PEG ratio of 4.67 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the business earned $1.32 EPS. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is presently 23.24%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on A. TD Cowen boosted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Wells Fargo & Company upped their target price on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, September 15th. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and upped their target price for the stock from $130.00 to $170.00 in a research note on Wednesday, October 8th. Barclays upped their target price on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Finally, Evercore ISI upped their target price on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.